Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 109
Inquire Before Buying

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

Market Analysis and Insights: Global Meningococcal Conjugate Market

The global Meningococcal Conjugate market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Conjugate market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Conjugate market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Conjugate market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Conjugate market.

Global Meningococcal Conjugate Scope and Market Size

Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Menactra

- Menveo

- NeisVac-C

- Nimenrix

- Others

Segment by Application

- Children

- Preteens or Teens

- Adults

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Sanofi Pasteur

- Pfizer

- Glaxo Smith Kline

- Hualan Biological Engineering

- JN International Medical Corporation

- Baxter International

- Merck

- Serum Institute of India

- Biomed

- Novartis

Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by Application
1.3.1 Global Meningococcal Conjugate Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2016-2027)
2.2 Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2016-2021)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027)
2.3 Meningococcal Conjugate Industry Dynamic
2.3.1 Meningococcal Conjugate Market Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2016-2021)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2016-2021)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2020
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2016-2021)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027)
5 Meningococcal Conjugate Breakdown Data by Application
5.1 Global Meningococcal Conjugate Historic Market Size by Application (2016-2021)
5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2016-2027)
6.2 North America Meningococcal Conjugate Market Size by Type
6.2.1 North America Meningococcal Conjugate Market Size by Type (2016-2021)
6.2.2 North America Meningococcal Conjugate Market Size by Type (2022-2027)
6.2.3 North America Meningococcal Conjugate Market Size by Type (2016-2027)
6.3 North America Meningococcal Conjugate Market Size by Application
6.3.1 North America Meningococcal Conjugate Market Size by Application (2016-2021)
6.3.2 North America Meningococcal Conjugate Market Size by Application (2022-2027)
6.3.3 North America Meningococcal Conjugate Market Size by Application (2016-2027)
6.4 North America Meningococcal Conjugate Market Size by Country
6.4.1 North America Meningococcal Conjugate Market Size by Country (2016-2021)
6.4.2 North America Meningococcal Conjugate Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2016-2027)
7.2 Europe Meningococcal Conjugate Market Size by Type
7.2.1 Europe Meningococcal Conjugate Market Size by Type (2016-2021)
7.2.2 Europe Meningococcal Conjugate Market Size by Type (2022-2027)
7.2.3 Europe Meningococcal Conjugate Market Size by Type (2016-2027)
7.3 Europe Meningococcal Conjugate Market Size by Application
7.3.1 Europe Meningococcal Conjugate Market Size by Application (2016-2021)
7.3.2 Europe Meningococcal Conjugate Market Size by Application (2022-2027)
7.3.3 Europe Meningococcal Conjugate Market Size by Application (2016-2027)
7.4 Europe Meningococcal Conjugate Market Size by Country
7.4.1 Europe Meningococcal Conjugate Market Size by Country (2016-2021)
7.4.2 Europe Meningococcal Conjugate Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2016-2027)
8.2 Asia-Pacific Meningococcal Conjugate Market Size by Type
8.2.1 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2027)
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Application
8.3.1 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2027)
8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region
8.4.1 Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2016-2027)
9.2 Latin America Meningococcal Conjugate Market Size by Type
9.2.1 Latin America Meningococcal Conjugate Market Size by Type (2016-2021)
9.2.2 Latin America Meningococcal Conjugate Market Size by Type (2022-2027)
9.2.3 Latin America Meningococcal Conjugate Market Size by Type (2016-2027)
9.3 Latin America Meningococcal Conjugate Market Size by Application
9.3.1 Latin America Meningococcal Conjugate Market Size by Application (2016-2021)
9.3.2 Latin America Meningococcal Conjugate Market Size by Application (2022-2027)
9.3.3 Latin America Meningococcal Conjugate Market Size by Application (2016-2027)
9.4 Latin America Meningococcal Conjugate Market Size by Country
9.4.1 Latin America Meningococcal Conjugate Market Size by Country (2016-2021)
9.4.2 Latin America Meningococcal Conjugate Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2016-2027)
10.2 Middle East & Africa Meningococcal Conjugate Market Size by Type
10.2.1 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2027)
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Application
10.3.1 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2027)
10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country
10.4.1 Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Details
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Details
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Details
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2016-2021)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Details
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2016-2021)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2016-2021)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Meningococcal Conjugate Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Meningococcal Conjugate Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Regions (2016-2021)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2016-2021)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Meningococcal Conjugate Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by Application (2016-2021)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Pasteur Company Details
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur Meningococcal Conjugate Product
Table 67. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 68. Sanofi Pasteur Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Meningococcal Conjugate Product
Table 72. Pfizer Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Glaxo Smith Kline Company Details
Table 75. Glaxo Smith Kline Business Overview
Table 76. Glaxo Smith Kline Meningococcal Conjugate Product
Table 77. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 78. Glaxo Smith Kline Recent Development
Table 79. Hualan Biological Engineering Company Details
Table 80. Hualan Biological Engineering Business Overview
Table 81. Hualan Biological Engineering Meningococcal Conjugate Product
Table 82. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 83. Hualan Biological Engineering Recent Development
Table 84. JN International Medical Corporation Company Details
Table 85. JN International Medical Corporation Business Overview
Table 86. JN International Medical Corporation Meningococcal Conjugate Product
Table 87. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 88. JN International Medical Corporation Recent Development
Table 89. Baxter International Company Details
Table 90. Baxter International Business Overview
Table 91. Baxter International Meningococcal Conjugate Product
Table 92. Baxter International Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 93. Baxter International Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Meningococcal Conjugate Product
Table 97. Merck Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Serum Institute of India Company Details
Table 100. Serum Institute of India Business Overview
Table 101. Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 102. Serum Institute of India Recent Development
Table 103. Biomed Company Details
Table 104. Biomed Business Overview
Table 105. Biomed Meningococcal Conjugate Product
Table 106. Biomed Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 107. Biomed Recent Development
Table 108. Novartis Company Details
Table 109. Novartis Business Overview
Table 110. Novartis Meningococcal Conjugate Product
Table 111. Novartis Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 112. Novartis Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Share by Type: 2020 VS 2027
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Market Share by Application: 2020 VS 2027
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Meningococcal Conjugate Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Meningococcal Conjugate Market Share by Regions: 2020 VS 2027
Figure 15. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Figure 16. Global Meningococcal Conjugate Market Share by Players in 2020
Figure 17. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2020
Figure 19. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Figure 20. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027)
Figure 21. North America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 23. North America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 24. North America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 25. United States Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 29. Europe Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 30. Europe Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 31. Germany Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Meningococcal Conjugate Market Share by Region (2016-2027)
Figure 41. China Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 49. Latin America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 50. Latin America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 51. Mexico Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 57. Turkey Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 62. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 63. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 64. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 65. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 67. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 68. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 29-Jul-2021        Price: US 5900 Onwards        Pages: 115
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. Global Influenza Vaccine main players include ......
  • Avian Influenza Vaccines Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 25-Jul-2021        Price: US 3200 Onwards        Pages: 92
    This report describes the global market size of Avian Influenza Vaccines from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also......
  • Global Avian Influenza Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 22-Jul-2021        Price: US 5900 Onwards        Pages: 141
    Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria. Global Avian Influenza V......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 19-Jul-2021        Price: US 5900 Onwards        Pages: 102
    23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually gi......
  • Global Encephalitis Vaccination Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 16-Jul-2021        Price: US 5900 Onwards        Pages: 119
    Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological ......
  • Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
    Published: 16-Jul-2021        Price: US 3900 Onwards        Pages: 109
    Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. Market Analysis and Insights: Global Meningococcal Conjugate Market The global Meningococcal Conjugate market size is projected to reach US$ XX million by 2027......
  • Global Encephalitis Vaccination Market Growth 2021-2026
    Published: 15-Jul-2021        Price: US 3660 Onwards        Pages: 95
    According to this latest study, the 2021 growth of Encephalitis Vaccination will have significant change from previous year. By the most conservative estimates of global Encephalitis Vaccination market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1196.1 million in 2020. Over the next five years the Encephalitis Vaccination market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 1499.2 million by 2026. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026
    Published: 14-Jul-2021        Price: US 3660 Onwards        Pages: 88
    According to this latest study, the 2021 growth of 23-Valent Pneumococcal Polysaccharide Vaccine will have significant change from previous year. By the most conservative estimates of global 23-Valent Pneumococcal Polysaccharide Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2326.5 million in 2020. Over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9% CAGR in terms of revenue, the g......
  • Global Encephalitis Vaccine Market Research Report 2021 Professional Edition
    Published: 13-Jul-2021        Price: US 2890 Onwards        Pages: 172
    The global Encephalitis Vaccine market was valued at 1152.9 Million USD in 2020 and will grow with a CAGR of 5.56% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Eur......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs